ROCkets/ROCkeTS-GEN
The ROCkeTS study is a diagnostic study which aims to validate new tests/risk prediction models that estimate the probability of having ovarian cancer in pre and post-menopausal women with symptoms. The ROCkeTS-GEN substudy is also a diagnostic study but only recruiting post-menopausal women with the aim of evaluating patients' circulating tumour DNA (ctDNA) using genome sequencing to determine if ctDNA can be used as a diagnostic biomarker and thus improve the sensitivity of detecting ovarian cancer.
Contact Information
- Email:
- rockets@trials.bham.ac.uk
- Telephone:
- 0121 415 9129
- Address:
-
Birmingham Clinical Trials Unit
Public Health Building
University of Birmingham
Edgbaston
Birmingham
West Midlands
B15 2TT
England
Last Updated: 03/01/2023
Annual Statistics
| Year | Access Requests Received | Access Requests Approved | ||||
|---|---|---|---|---|---|---|
| Internal | External | Commercial | Internal | External | Commercial | |
| 2015 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2016 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2017 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2018 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2019 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2020 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2021 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2022 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2023 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2024 | N/A | N/A | N/A | N/A | N/A | N/A |